Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
  • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
  • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
  • A61P37/02—Immunomodulators
  • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
  • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
  • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
  • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
  • G01N33/56966—Animal cells
  • G01N33/56972—White blood cells
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2600/00—Oligonucleotides characterized by their use
  • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2600/00—Oligonucleotides characterized by their use
  • C12Q2600/156—Polymorphic or mutational markers
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Immunology (AREA)
• Organic Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Biomedical Technology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Medicinal Chemistry (AREA)
• Molecular Biology (AREA)
• Cell Biology (AREA)
• Hematology (AREA)
• Analytical Chemistry (AREA)
• Urology & Nephrology (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Zoology (AREA)
• Pathology (AREA)
• Biotechnology (AREA)
• Biochemistry (AREA)
• Physics & Mathematics (AREA)
• Microbiology (AREA)
• Genetics & Genomics (AREA)
• Wood Science & Technology (AREA)
• Tropical Medicine & Parasitology (AREA)
• Food Science & Technology (AREA)
• General Physics & Mathematics (AREA)
• Neurosurgery (AREA)
• Neurology (AREA)
• General Engineering & Computer Science (AREA)
• Biophysics (AREA)
• Virology (AREA)
• Ecology (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=48142792

Family Applications (1)

Country Status (19)

Families Citing this family (9)

Family Cites Families (4)

• 2013
  • 2013-04-19 BR BR112015020140A patent/BR112015020140A8/pt not_active IP Right Cessation
  • 2013-04-19 RU RU2015141151A patent/RU2015141151A/ru unknown
  • 2013-04-19 EP EP22214476.8A patent/EP4191245A3/en not_active Withdrawn
  • 2013-04-19 CA CA2900844A patent/CA2900844C/en active Active
  • 2013-04-19 US US14/781,922 patent/US20160046573A1/en not_active Abandoned
  • 2013-04-19 SG SG10201707826RA patent/SG10201707826RA/en unknown
  • 2013-04-19 JP JP2016505716A patent/JP6240746B2/ja active Active
  • 2013-04-19 EP EP13717513.9A patent/EP2981819A1/en not_active Withdrawn
  • 2013-04-19 SG SG11201506493VA patent/SG11201506493VA/en unknown
  • 2013-04-19 WO PCT/EP2013/058226 patent/WO2014161606A1/en not_active Ceased
  • 2013-04-19 EP EP19204477.4A patent/EP3647783B1/en active Active
  • 2013-04-19 AU AU2013385181A patent/AU2013385181A1/en not_active Abandoned
  • 2013-04-19 MX MX2015014014A patent/MX2015014014A/es unknown
  • 2013-04-19 EP EP24214581.1A patent/EP4556908A3/en active Pending
  • 2013-04-19 ES ES19204477T patent/ES2941941T3/es active Active
  • 2013-04-19 CA CA3149287A patent/CA3149287A1/en active Pending
  • 2013-04-19 KR KR1020157026787A patent/KR102166228B1/ko not_active Expired - Fee Related
  • 2013-04-19 HK HK16101571.7A patent/HK1213636A1/zh unknown
  • 2013-04-19 EP EP17157993.1A patent/EP3199947A3/en not_active Withdrawn
  • 2013-04-25 TW TW102114869A patent/TW201438716A/zh unknown
  • 2013-05-03 AR ARP130101514A patent/AR090929A1/es unknown
• 2015
  • 2015-08-03 TN TN2015000333A patent/TN2015000333A1/en unknown
  • 2015-10-02 PH PH12015502291A patent/PH12015502291A1/en unknown
  • 2015-10-02 CL CL2015002933A patent/CL2015002933A1/es unknown
• 2017
  • 2017-04-13 AU AU2017202470A patent/AU2017202470A1/en not_active Abandoned
  • 2017-05-24 IL IL252497A patent/IL252497B/en unknown
  • 2017-05-25 US US15/605,277 patent/US20170320820A1/en not_active Abandoned
  • 2017-11-02 JP JP2017213116A patent/JP2018076316A/ja not_active Withdrawn
• 2018
  • 2018-09-20 US US16/136,630 patent/US20190135744A1/en not_active Abandoned
• 2019
  • 2019-01-23 JP JP2019009208A patent/JP6934481B2/ja active Active
  • 2019-03-25 AU AU2019202036A patent/AU2019202036B2/en active Active
• 2020
  • 2020-06-03 US US16/891,898 patent/US20210147354A1/en not_active Abandoned
• 2021
  • 2021-07-20 IL IL284999A patent/IL284999A/en unknown
• 2024
  • 2024-04-09 US US18/630,271 patent/US20240270688A1/en not_active Abandoned
• 2025
  • 2025-09-05 US US19/320,102 patent/US20260001839A1/en active Pending

Also Published As

Similar Documents